Clinical Trials Browser

Terminated × Advanced Solid Tumors × pembrolizumab × Clear all

NCT04074759 2025-01-23

FPT155-001

Phase 1 Terminated

80 enrolled 49 charts

Other solid neoplasm

Advanced Solid Tumors

NCT05394350 2024-11-08

MK-1088-002

Phase 1/2 Terminated

27 enrolled 19 charts

Other solid neoplasm

Advanced Solid Tumors

NCT02880371 2022-06-16

A Study of ARRY-382 in Combination With Pembrolizumab for the Treatment of Patients With Advanced Solid Tumors

Phase 1/2 Terminated

82 enrolled 32 charts

Other solid neoplasm

Advanced Solid Tumors